Equillium (EQ) Cash from Operations (2018 - 2026)
Equillium's (EQ) quarterly Cash from Operations came in at 4301000.0 in Q1 2026, up 47.35% year-on-year from 2918905.79 in Q1 2025, and down 37.28% on a QoQ basis from 3133000.0 in Q4 2025.
Equillium (EQ) Cash from Operations (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Cash from Operations data on file, last reported at 4301000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 47.35% year-over-year to 4301000.0 in Q1 2026; TTM through Mar 2026 was 18878000.0, a 2.63% decrease from a year earlier, with the FY2025 full-year figure at 22746000.0, down 19.55% from the prior year.
- Cash from Operations for Q1 2026 stood at 4301000.0, down from 3133000.0 in the prior quarter.
- Over the last five years, Cash from Operations for EQ reached as high as 27725000.0 in Q4 2022 and fell as low as 13065000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 4505235.29 across 5 years, with a median of 6215000.0 in 2023.
- Across the five-year window, Cash from Operations surged 373.61% in 2022 and sank 512.74% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 27725000.0 in 2022, then sank by 120.43% to 5664000.0 in 2023, then jumped by 41.75% to 3299000.0 in 2024, then climbed by 5.03% to 3133000.0 in 2025, then plunged by 37.28% to 4301000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 4301000.0 in Q1 2026, 3133000.0 in Q4 2025, and 8431000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | -4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.30 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | -3.13 Mn |
| Dec 31, 2025 | -3.13 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Jun 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Mar 31, 2024 | -8.80 Mn |
| Mar 31, 2024 | -8.80 Mn |
| Dec 31, 2023 | -5.66 Mn |
| Dec 31, 2023 | -5.66 Mn |